MedTrace Logo

Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

NCT02917200 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2017-09-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether different DAV132 dose regimens are safe and effective for capturing fecal residues of moxifloxacin in healthy volunteers.

Conditions

  • Healthy Subjects

Interventions

DRUG

Moxifloxacin

Oral route

DEVICE

DAV132

Oral route

OTHER

Negative control

Oral route

Sponsors & Collaborators

  • Da Volterra

    lead INDUSTRY

Principal Investigators

  • Yves Donazzolo · Eurofins Optimed

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-11
Primary Completion
2016-12-02
Completion
2016-12-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917200 on ClinicalTrials.gov